Molecular Characterization and Azole Resistance Patterns of Candida Species Colonizing Sputum of Pulmonary Tuberculosis Patients in Mumbai, India

Background: Pulmonary tuberculosis (PTB) generates a compromised pulmonary environment that predisposes patients to opportunistic fungal colonization. While Candida albicans remains predominant, emerging non-albicans Candida species require molecular surveillance. Objective: We have to evaluate the prevalence, species distribution, molecular identity, and antifungal susceptibility profiles of Candida species isolated from sputum of PTB patients at a tertiary care center in Mumbai, India. Methods: A hospital-based cross-sectional study was conducted from June 2021 to December 2023. A total of 650 PTB sputum samples were processed successfully. Gram staining was used in phenotypic identification, KOH mount, germ tube testing, and chromogenic agar. Genotypic confirmation carried ITS region PCR amplification and Sanger sequencing with NCBI BLAST analysis. Antifungal susceptibility testing of Candida akabanensis isolates was performed by using the Semi-Solid Agar Antifungal Susceptibility (SAAS) screening method. Results: Candida was isolated from 192 of 650 specimens (29.54%). Among positive isolates, females comprised 61.46% and males 38.54%. Peak isolation occurred in the 28–37 years age group (31.77%). Species distribution: C. albicans 63.02%, Nakaseomyces glabratus 24.48%, C. akabanensis 11.46%, and C. tropicalis 1.04%. Among 22 C. akabanensis isolates, resistance rates were ketoconazole 68.18%, griseofulvin 59.09%, and fluconazole 45.45%, with 100% susceptibility to nystatin, itraconazole, and terbinafine. Conclusion: Considerable Candida co-colonization is present among PTB patients in Mumbai, including recovery of the uncommon species C. akabanensis. Be aware to routine mycological screening with molecular identification is recommended to guide appropriate antifungal selection. Clinical significance of colonization versus invasive infection requires further evaluation. Keywords: Pulmonary tuberculosis, Candida akabanensis, ITS sequencing, Antifungal susceptibility, Co-colonization, Mumbai

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-07
DOI
https://doi.org/10.5281/zenodo.24030944
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular Characterization and Azole Resistance Patterns of Candida Species Colonizing Sputum of Pulmonary Tuberculosis Patients in Mumbai, India

Meenesh Kulkarni
1 links
Zenodo (CERN European Organization for Nuclear Research)
Antifungal resistance and susceptibility
article

Molecular Characterization and Azole Resistance Patterns of Candida Species Colonizing Sputum of Pulmonary Tuberculosis Patients in Mumbai, India

Meenesh Kulkarni
article en

Abstract

Background: Pulmonary tuberculosis (PTB) generates a compromised pulmonary environment that predisposes patients to opportunistic fungal colonization. While Candida albicans remains predominant, emerging non-albicans Candida species require molecular surveillance. Objective: We have to evaluate the prevalence, species distribution, molecular identity, and antifungal susceptibility profiles of Candida species isolated from sputum of PTB patients at a tertiary care center in Mumbai, India. Methods: A hospital-based cross-sectional study was conducted from June 2021 to December 2023. A total of 650 PTB sputum samples were processed successfully. Gram staining was used in phenotypic identification, KOH mount, germ tube testing, and chromogenic agar. Genotypic confirmation carried ITS region PCR amplification and Sanger sequencing with NCBI BLAST analysis. Antifungal susceptibility testing of Candida akabanensis isolates was performed by using the Semi-Solid Agar Antifungal Susceptibility (SAAS) screening method. Results: Candida was isolated from 192 of 650 specimens (29.54%). Among positive isolates, females comprised 61.46% and males 38.54%. Peak isolation occurred in the 28–37 years age group (31.77%). Species distribution: C. albicans 63.02%, Nakaseomyces glabratus 24.48%, C. akabanensis 11.46%, and C. tropicalis 1.04%. Among 22 C. akabanensis isolates, resistance rates were ketoconazole 68.18%, griseofulvin 59.09%, and fluconazole 45.45%, with 100% susceptibility to nystatin, itraconazole, and terbinafine. Conclusion: Considerable Candida co-colonization is present among PTB patients in Mumbai, including recovery of the uncommon species C. akabanensis. Be aware to routine mycological screening with molecular identification is recommended to guide appropriate antifungal selection. Clinical significance of colonization versus invasive infection requires further evaluation. Keywords: Pulmonary tuberculosis, Candida akabanensis, ITS sequencing, Antifungal susceptibility, Co-colonization, Mumbai

Zenodo (CERN European Organization for Nuclear Research)
Topiwala National Medical College & BYL Nair Charitable Hospital (IN)
Good health and well-being
Openalex Percentile: Top 14%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon